TrendFlares logo

Akebia Therapeutics, Inc. (AKBA)

$1.37 1.48% $0.02 Healthcare

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

$288.09M

Mr. John P. Butler MBA

426.00

Cambridge, MA

Mar 20, 2014

-6.52

$-0.21

0.37

1.04

-23.18%

-7.10

-1.55

-8.51

1.65

0.82

-18.37%

123.47%

Downtrend

Similar stocks (9)

Seres Therapeutics, Inc.

MCRB

$1.05 0.00%
Uptrend

X4 Pharmaceuticals, Inc.

XFOR

$0.71 0.63%
Downtrend

Protalix BioTherapeutics, Inc.

PLX

$1.15 5.50%
Downtrend

Cidara Therapeutics, Inc.

CDTX

$11.72 0.86%
Downtrend

Elevation Oncology, Inc.

ELEV

$0.60 0.94%
Downtrend

Ocean Biomedical, Inc.

OCEA

$0.99 1.28%
Downtrend

Enveric Biosciences, Inc.

ENVB

$0.49 -0.02%
Downtrend

Hepion Pharmaceuticals, Inc.

HEPA

$0.68 0.37%
Downtrend

CohBar, Inc.

CWBR

$0.49 2.07%
Downtrend

ETF Exposure (25)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.625%

$27.51 1.81%
Uptrend

iShares Micro-Cap ETF

IWC

0.07679%

$126.54 2.19%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.02116%

$170.39 1.83%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$150.33 1.93%
Uptrend

iShares Russell 2000 ETF

IWM

0.01158%

$223.97 2.06%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07%
Uptrend

ProShares Ultra Russell2000

UWM

0.004252137216760447%

$44.09 4.26%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.0022%

$285.77 2.18%
Uptrend

ProShares UltraPro Russell2000

URTY

0.002096177598171185%

$54.27 6.25%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0017787162395047772%

$50.07 0.41%
Uptrend

iShares Russell 3000 ETF

IWV

0.00106%

$325.63 1.75%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

9.5e-4%

$125.25 1.78%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$70.22 2.36%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0%

$208.30 2.26%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend